OLEMA PHARMACEUTICALS, INC. Earnings Per Share (Diluted)
OLEMA PHARMACEUTICALS, INC. (OLMA) reported Earnings Per Share (Diluted) of -$0.61 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-10
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.61.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.52.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.50.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.49.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2025 was -$1.87.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2024 was -$2.20.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2023 was -$2.14.
- OLEMA PHARMACEUTICALS, INC. earnings per share, diluted for fiscal 2022 was -$2.62.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$0.61 10-Q · filed 2026-08-10 | -$1.12 10-Q · filed 2026-08-10 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$2.13 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2026-03-31 | -$0.52 10-Q · filed 2026-05-12 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.52 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$2.03 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.51 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.87 10-K · filed 2026-03-16 | |
| 2025-09-30 | -$0.49 10-Q · filed 2025-11-10 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.36 10-Q · filed 2025-11-10 | -$1.81 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-06-30 | -$0.51 10-Q · filed 2026-08-10 | -$0.87 10-Q · filed 2026-08-10 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-08-10 | -$1.87 derived: net income ÷ weighted average shares · filed 2026-08-10 | |
| 2025-03-31 | -$0.36 10-Q · filed 2026-05-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-05-12 | |
| 2024-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.20 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$0.60 10-Q · filed 2025-11-10 | -$1.14 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$1.80 10-Q · filed 2025-11-10 | -$2.19 derived: net income ÷ weighted average shares · filed 2026-04-29 | |
| 2024-06-30 | -$0.54 10-Q · filed 2025-08-11 | -$1.10 10-Q · filed 2025-08-11 | -$1.58 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.07 derived: net income ÷ weighted average shares · filed 2026-04-29 | |
| 2024-03-31 | -$0.56 10-Q · filed 2025-05-13 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.53 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.02 derived: net income ÷ weighted average shares · filed 2026-04-29 | |
| 2023-12-31 | -$0.49 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$1.46 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$2.14 10-K · filed 2025-03-18 | |
| 2023-09-30 | -$0.48 10-Q · filed 2024-11-12 | -$0.97 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.66 10-Q · filed 2024-11-12 | -$2.31 derived: net income ÷ weighted average shares · filed 2024-11-12 | |
| 2023-06-30 | -$0.49 10-Q · filed 2024-08-06 | -$1.20 10-Q · filed 2024-08-06 | -$1.84 derived: net income ÷ weighted average shares · filed 2024-08-06 | -$2.41 derived: net income ÷ weighted average shares · filed 2024-08-06 | |
| 2023-03-31 | -$0.70 10-Q · filed 2024-05-08 | -$0.69 10-Q · filed 2023-05-09 | -$1.35 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.92 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$2.74 derived: net income ÷ weighted average shares · filed 2024-05-08 |
| 2022-12-31 | -$0.65 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$1.22 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-03-11 | -$2.62 10-K · filed 2024-03-11 | |
| 2022-09-30 | -$0.57 10-Q · filed 2023-11-07 | -$1.39 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.97 10-Q · filed 2023-11-07 | -$2.51 derived: net income ÷ weighted average shares · filed 2023-11-07 | |
| 2022-06-30 | -$0.82 10-Q · filed 2023-08-08 | -$1.40 10-Q · filed 2023-08-08 | -$1.95 derived: net income ÷ weighted average shares · filed 2023-08-08 | -$2.39 derived: net income ÷ weighted average shares · filed 2023-08-08 | |
| 2022-03-31 | -$0.58 10-Q · filed 2023-05-09 | -$1.12 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.57 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$1.99 derived: net income ÷ weighted average shares · filed 2023-05-09 | |
| 2021-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.41 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$1.80 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-08 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.25 10-Q · filed 2022-11-08 | -$1.72 derived: net income ÷ weighted average shares · filed 2022-11-08 | |
| 2021-06-30 | -$0.42 10-Q · filed 2022-08-09 | -$0.81 10-Q · filed 2022-08-09 | -$1.27 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$1.96 derived: net income ÷ weighted average shares · filed 2022-08-09 | |
| 2021-03-31 | -$0.39 10-Q · filed 2022-05-09 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$1.61 derived: net income ÷ weighted average shares · filed 2022-05-09 | -$2.21 derived: net income ÷ weighted average shares · filed 2022-05-09 | |
| 2020-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$1.57 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$2.41 derived: net income ÷ weighted average shares · filed 2022-02-28 | -$3.42 10-K · filed 2022-02-28 | |
| 2020-09-30 | -$3.71 10-Q · filed 2021-11-10 | -$3.95 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$5.29 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$0.95 10-Q · filed 2021-08-10 | -$1.60 10-Q · filed 2021-08-10 | |||
| 2019-12-31 | -$1.66 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |